BioCentury
ARTICLE | Clinical News

Sebclair regulatory update

November 6, 2006 8:00 AM UTC

FDA granted 510(k) clearance to Sebclair to treat seborrheic dermatitis. Chester Valley (Malvern, Penn.) has U.S. marketing rights to the non-steroidal cream, which FDA classified as a device, and exp...